Comprehensive History for Pigmentary Dermatosis
When evaluating a patient with pigmentary dermatosis, obtain a detailed history focusing on: onset and progression timeline, distribution pattern, associated symptoms, medication/cosmetic use, family history, psychological impact, and presence of extracutaneous manifestations.
Essential Historical Elements
Temporal Characteristics
- Onset: Document whether the pigmentation appeared suddenly or insidiously, as this distinguishes different entities within the spectrum 1
- Duration: Note if this is a longstanding condition (years to decades) versus recent onset 2
- Progression: Determine if lesions are stable, spreading, or fluctuating over time
Pattern and Distribution
- Location: Facial involvement is particularly common and psychologically impactful 3
- Symmetry: Symmetrical patterns suggest vitiligo or melasma, while asymmetric patterns may indicate other diagnoses 4
- Configuration: Document whether lesions are reticulated, confluent, or macular 1, 2
Pigmentation Characteristics
- Type: Distinguish between hyperpigmentation (most common at 43-50% of cases), hypopigmentation, or combined patterns 5
- Color: Grey-to-brown macules suggest dermal melanin deposition, while darker confluent pigmentation may indicate overlapping conditions 1, 2
Associated Factors
Medication and Product Exposure:
- Topical steroid use (overlapping presentations with steroid-damaged face are common) 3
- Cosmetic products (relevant for Riehl melanosis/pigmented cosmetic dermatitis) 1
- Systemic medications
Extracutaneous Manifestations: This is critical, as 56% of pigmentary mosaicism patients have systemic involvement 5:
- Central nervous system abnormalities (73% in hypopigmentation cases) 5
- Musculoskeletal abnormalities
- Developmental concerns
Psychosocial Impact Assessment
Quality of life evaluation is mandatory 4, 3:
- Emotional burden often disproportionate to physical symptoms 3
- Social anxiety and coping mechanisms 4
- Impact on daily functioning
- For children: assess parental psychological state, as counseling may be needed 4
Family and Genetic History
- Family history of pigmentary disorders
- Autoimmune conditions (particularly relevant for vitiligo) 4
- Genetic syndromes
Critical Pitfalls to Avoid
Do not assume isolated cutaneous disease: Even in patients without obvious extracutaneous manifestations, 32% may have abnormal karyotypes, compared to 43% in those with systemic findings 5. Both groups warrant cytogenetic evaluation.
Do not overlook overlapping diagnoses: Multiple pigmentary conditions frequently coexist (e.g., melasma with topical steroid damage), requiring recognition of combined patterns 3.
Do not minimize psychological impact: The emotional burden requires formal assessment using validated tools, as this should be the primary outcome measure in management 4.